# Charles Sutphin

Charles Sutphin is a remote worker on Himalayas, Private Investor at Southwest Virginia, based in United States.

Source: https://himalayas.app/@charlessutphin

```text
Strategy and corporate development executive who closed pharmaceutical deals with GSK Canada, 3M, Santarus, and Henry Schein.
```

| Detail | Value |
| --- | --- |
| Availability | Looking for a job |
| Location | United States |
| Authorized to work in | United States |
| Salary expectations | 200k+ USD |
| Job categories | Corporate Development Executive, Strategic Executive, Mergers and Acquisitions Executive |
| Skills | Corporate Strategy, Corporate Development, M&A, Licensing, Partnerships, Valuation Models, Due Diligence, Capital Raising, Investment Analysis, Financial Modeling, Market Analysis, Reimbursement Analysis, Regulatory Strategy, Commercial Strategy, Negotiation |

## About

```text
I secured Canadian rights to Lanoxin from GSK Canada and US rights to Urex from 3M, then grew Vatring to $18M in annualized revenue. I modernized Urex’s formulation after 3M stopped manufacturing, winning FDA approval through a 505(b)(2) filing.

At S2 Therapeutics, I acquired worldwide rights to Cycloset, led an $18M private equity raise, and financed its development through FDA approval. I also advised on Santarus’s US launch and clinical direction.

At Wohlfahrt Haus, I helped shape a dinner theater around Broadway musicals and a full-service restaurant, later taking full operating control. I secured more than $1.1M in COVID relief grants and executed the sale of the theater assets to Red Stag, LLC in 2025.
```

## Experience

### Private Investor (current)

Southwest Virginia. Jan 2025 - Present

```text
Manages five homes, 100+ acres, and an actively traded equities and options portfolio.
```

Skills: Investment-Management, Portfolio-Management, Real-Estate

### Co-Founder and Managing Member (current)

Wohlfahrt Haus, LLC. Jan 1998 - Present

```text
Co-founded and managed a 250-seat dinner theater staging Broadway musicals and concerts, plus a 70-seat restaurant, with annual revenue around $3M. Secured over $1.1M in relief grants during COVID and executed the sale of theater assets in 2025.
```

Skills: Business-Management, Strategic-Planning, Grant-writing, Financial-Oversight, Operations-Management

### Strategic Advisor

PS Fertility. Jan 2022 - Dec 2022

```text
Evaluated a male bovine fertility test's central-lab model, advising on competitive exposure and path to human commercial viability.
```

Skills: Market-Analysis, Commercial-Viability, Advisory

### Strategic Advisor

Molecular Biologics. Jan 2021 - Dec 2022

```text
Advised on navigating a significant reimbursement gap for a finished packaged product, addressing Medicaid A category reimbursement issues.
```

Skills: Reimbursement-Strategy, Advisory, Healthcare-Policy

### Corporate Development Consultant

Pernix Therapeutics, Inc.. Jan 2012 - Dec 2013

```text
Sourced and analyzed potential M&A targets at both the product and corporate levels.
```

Skills: M&A, Due-Diligence, Financial-Analysis

### Co-Founder, Chairman, and CEO

Vatring Holdings, Inc.. Jan 1998 - Dec 2012

```text
Co-founded and led pharmaceutical companies, securing rights to Lanoxin and Urex, scaling to $18M in revenue, and divesting assets. Modernized manufacturing processes and obtained regulatory approvals.
```

Skills: Corporate-Strategy, M&A, Licensing, Regulatory-Affairs, Manufacturing, Commercial-Strategy

### Co-Founder and Manager

Royalpharm, LLC. Jan 2009 - Dec 2011

```text
Negotiated the acquisition of Cycloset royalty rights from Teva, following the NDA transfer and global commercial rights arrangement.
```

Skills: Negotiation, Licensing, Royalty-Management

### Co-Founder and CEO

S2 Therapeutics, Inc.. Jan 2005 - Dec 2011

```text
Co-founded and led a pharmaceutical company, acquiring worldwide rights to Cycloset and licensing US rights to Santarus. Raised $18M in private equity and guided the product through clinical trials to FDA approval.
```

Skills: Pharmaceutical-Development, Clinical-Trials, Fundraising, Licensing, Regulatory-Strategy

### Founder and Managing Member

Niftus, LLC. Jan 1998 - Dec 2002

```text
Founded and managed a company that built Medline For Physicians, Inc., growing a team of 40 and selling the customer base to Henry Schein. Closed a $2M revolving credit facility for speculative purchases.
```

Skills: Business-Development, Sales, Credit-Management, Team-Leadership

### VP, Marketing and Business Development

General Injectables and Vaccines, Inc.. Jan 1992 - Dec 1998

```text
Rose from Sales Associate to VP, Marketing and Business Development. Built forecasting and ROI models, closed exclusive agreements, and managed private-label deals that netted over $6.5M.
```

Skills: Marketing, Business-Development, Forecasting, ROI-Modeling, Contract-Negotiation

### Manager, Trade Relations

Lotus Biochemical, Inc.. Jan 1993 - Dec 1995

```text
Led a co-promotion team that grew Ionamin sales by 10x, and managed re-launch and trade logistics for multiple products across wholesale, chain, and independent pharmacies.
```

Skills: Trade-Relations, Team-Leadership, Sales-Growth, Logistics

## Education

### Virginia Tech

MBA, Finance

```text
Earned an MBA and a B.S. in Finance (Corporate) from the Pamplin College of Business.
```

### Virginia Tech

B.S., Finance

```text
Earned a B.S. in Finance (Corporate) from the Pamplin College of Business.
```

## Tech stack

- Microsoft Excel

To contact Charles, message them from this profile with a Himalayas employer account: [Hire on Himalayas](https://himalayas.app/hire).

## People also viewed

- [John Lustig](https://himalayas.app/@johnlustig): DIRECTOR NEW BUSINESS GM, RPM & CLINICAL PROGRAMS, OMRON HEALTHCARE
- [Thane Gauthier](https://himalayas.app/@thanegauthier): Vice President, Finance/Corporate Development, SagePak LLC
- [Gregg Goldenberg](https://himalayas.app/@gregggoldenberg): Sr. Vice President, Corporate Development, Healthcare
- [Princess Swan](https://himalayas.app/@princessswan): Special Projects Manager, Infinite Reality
- [Rachel Qiu](https://himalayas.app/@rachelqiu): Investment Principal, Telus Global Ventures
- [John Mackay](https://himalayas.app/@johnmackay): Professional Development Sabbatical, Professional Development Sabbatical
- [Jasper Gallo](https://himalayas.app/@jaspergallo): Founding Partner, PRH Private Capital
- [Amelia Presley](https://himalayas.app/@ameliapresley): Vice President Marketing, Sysmex America, Inc.
- [Bryce Chaney](https://himalayas.app/@brycechaney): Sales Agent, Symmetry Financial Group
- [Sriman Poladi](https://himalayas.app/@srimanpoladi): Strategic Initiatives Associate Manager, PureRx
